NCT03816345 2026-03-18Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerNational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT05635266 2024-05-07Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesSanguine BiosciencesRecruiting20,000 enrolled